search button
Open Access

Secondary leiomyosarcoma of the nasal cavity in a treated patient with possible hereditary retinoblastoma with germline reciprocal translocation of RB1 and DMXL1 and somatic TP53 mutation: A case report

  • Authors:
    • Toshinari Yagi
    • Harumi Nakamura
    • Yoji Kukita
    • Toru Wakamatsu
    • Hironari Tamiya
    • Shou Nakai
    • Makiyo Watanabe
    • Shigeki Kakunaga
    • Haruna Takami
    • Rie Suzuki
    • Satoshi Takenaka
    • Yoshiko Hashii

  • View Affiliations

  • Published online on: July 10, 2023     https://doi.org/10.3892/mco.2023.2661
  • Article Number: 65

  • Copyright: © Yagi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Retinoblastoma is a common primary intraocular malignant tumor that affects infants and young children. Radiation therapy for hereditary retinoblastoma increases the risk of secondary malignancy. The present report discusses the case of a retinoblastoma survivor who developed secondary leiomyosarcoma 42 years after receiving radiation therapy. The retinoblastoma of the patient was unilateral, and the patient had no family history of the disease. RNA and DNA panel sequencing of the leiomyosarcoma tissue was performed to elucidate the molecular mechanism of this secondary malignancy. The RNA panel sequencing detected a germline reciprocal translocation of RB1 and DMXL1, leading to a diagnosis of possible hereditary retinoblastoma. Furthermore, it detected a somatic fusion gene (RAD51‑KNL1). The DNA panel sequencing identified various germline or somatic variants, including a somatic splice acceptor site mutation of TP53. We hypothesized that the molecular mechanism of the secondary malignancy of this patient was the combination of a germline reciprocal translocation of RB1 and DMXL1 and the accumulation of various somatic mutations containing the splice acceptor site mutation of TP53, which ultimately led to the development of a secondary leiomyosarcoma. Further prospective investigations are necessary to fully understand the role of reciprocal translocation of RB1 and DMXL1 or other mutations in the tumorigenesis of second malignancies in patients with hereditary retinoblastoma.
View Figures
View References

Related Articles

Journal Cover

August-2023
Volume 19 Issue 2

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 1.4
  • Ranked
    (total number of cites)
  • CiteScore: 2.8
  • CiteScore Rank: Q3: #250/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.55
  • SCImago Journal Rank (SJR): 0.446
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Yagi T, Nakamura H, Kukita Y, Wakamatsu T, Tamiya H, Nakai S, Watanabe M, Kakunaga S, Takami H, Suzuki R, Suzuki R, et al: Secondary leiomyosarcoma of the nasal cavity in a treated patient with possible hereditary retinoblastoma with germline reciprocal translocation of RB1 and DMXL1 and somatic TP53 mutation: A case report. Mol Clin Oncol 19: 65, 2023
APA
Yagi, T., Nakamura, H., Kukita, Y., Wakamatsu, T., Tamiya, H., Nakai, S. ... Hashii, Y. (2023). Secondary leiomyosarcoma of the nasal cavity in a treated patient with possible hereditary retinoblastoma with germline reciprocal translocation of RB1 and DMXL1 and somatic TP53 mutation: A case report. Molecular and Clinical Oncology, 19, 65. https://doi.org/10.3892/mco.2023.2661
MLA
Yagi, T., Nakamura, H., Kukita, Y., Wakamatsu, T., Tamiya, H., Nakai, S., Watanabe, M., Kakunaga, S., Takami, H., Suzuki, R., Takenaka, S., Hashii, Y."Secondary leiomyosarcoma of the nasal cavity in a treated patient with possible hereditary retinoblastoma with germline reciprocal translocation of RB1 and DMXL1 and somatic TP53 mutation: A case report". Molecular and Clinical Oncology 19.2 (2023): 65.
Chicago
Yagi, T., Nakamura, H., Kukita, Y., Wakamatsu, T., Tamiya, H., Nakai, S., Watanabe, M., Kakunaga, S., Takami, H., Suzuki, R., Takenaka, S., Hashii, Y."Secondary leiomyosarcoma of the nasal cavity in a treated patient with possible hereditary retinoblastoma with germline reciprocal translocation of RB1 and DMXL1 and somatic TP53 mutation: A case report". Molecular and Clinical Oncology 19, no. 2 (2023): 65. https://doi.org/10.3892/mco.2023.2661